UBS Group
GRDN

UBS Group’s Guardian Pharmacy Services GRDN Stock Holding History

UBS Group’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
72,519
+41,784
+136% +$1.62M ﹤0.01% 4688
2026
Q1 		$1.16M Buy
30,735
+12,640
+70% +$413K ﹤0.01% 5441
2025
Q4 		$544K Sell
18,095
-18,665
-51% -$528K ﹤0.01% 6024
2025
Q3 		$964K Sell
36,760
-13,412
-27% -$320K ﹤0.01% 5604
2025
Q2 		$1.07M Buy
50,172
+44,839
+841% +$1.01M ﹤0.01% 5404
2025
Q1 		$113K Sell
5,333
-284
-5% -$5.83K ﹤0.01% 6959
2024
Q4 		$114K Buy
+5,617
New +$116K ﹤0.01% 6788

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

UBS Group's GRDN Position: Q2 2026 in Review

UBS Group increased its Guardian Pharmacy Services (GRDN) stake by 136% in Q2 2026, buying an estimated $1.62M and bringing the position to 72,519 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #4688.

UBS Group first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • UBS Group held 72,519 shares of Guardian Pharmacy Services worth $3.04M as of Q2 2026.
  • UBS Group bought 41,784 Guardian Pharmacy Services shares in Q2 2026, an estimated $1.62M.
  • Guardian Pharmacy Services made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4688 holding.
  • UBS Group first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.